Spencer Talbot

Spencer Talbot is an associate in Robins Kaplan’s Antitrust and Trade Regulation Group where he focuses on antitrust litigation. Spencer has represented both plaintiffs and defendants in civil and criminal antitrust matters across numerous industries, including pharmaceuticals, life sciences, technology, consumer goods, entertainment, retail, and construction. Prior to joining Robins Kaplan, Spencer was an antitrust associate for a large international law firm in New York and clerked for two federal district court judges in the Eastern District of California.

Spencer received his J.D. from Cornell Law School, where he was a Notes Editor for the Cornell Law Review. He received his B.A. from University of California, San Diego.

Education

• Cornell Law School (2022); Cornell Law Review, Notes Editor (2020-2022)

• University of California, San Diego, B.A. in Comparative Politics and International Business, cum laude, Phi Beta Kappa (2019)

Representative Matters

• Represented Bruker in antitrust claims against 10x Genomics and Harvard College for allegedly monopolizing the worldwide Single-Cell Spatial Transcriptomics market by refusing to license at-issue patents. 10X Genomics, Inc. et al. v. Bruker Spatial Biology Inc. et al., No. 1:22-cv-00261 (D. Del.) (Prior to joining Robins Kaplan LLP)
• Represented Regeneron Pharmaceuticals in connection with monopolization, restraint of trade, and other claims against Novartis Pharmaceuticals and Vetter Pharma relating to actions taken to prevent Regeneron from competing in the anti-VEGF pre-filled syringe market. Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG, et al., 1:20-cv-05502 (S.D.N.Y.) (Prior to joining Robins Kaplan LLP)
• Represented Serta Simmons Bedding in connection with the FTC investigation, and subsequent litigation, of Tempur Sealy’s acquisition of Mattress Firm. Federal Trade Commission v. Tempur Sealy International, Inc. and Mattress Firm Group Inc., No. 4:24-cv-02508 (S.D. Tex.) (Prior to joining Robins Kaplan LLP).